Literature DB >> 6861781

The influence of bilirubin, alcohol and certain drugs on the kinetics of 99mTc-Diethyl IDA (EHIDA) in humans.

J M Coenegracht, T L Oei, P J van Breda Vriesman.   

Abstract

On the basis of the mathematical analysis of 99mTc-EHIDA hepatobiliary time-activity curves of normal individuals two rate constants, one related to accumulation of radioactivity (uptake) and the other to excretion, were calculated indicating a two-compartmental model. By means of computerized fitting the rate constant of excretion (Kb), the time of maximum uptake (Tmax) and the rate constant of uptake (Ka) were calculated. In severely jaundiced patients (serum bilirubin concentrations greater than 140 mumol/l) a markedly decreased or absent uptake of 99mTc-EHIDA was observed. In moderately jaundiced patients a low Kb was invariably observed; in obstructive jaundice due to malignant disease--but not in jaundice of benign obstructive or hepatocellular origin--an increase in Ka was frequently present. This latter finding was not always present, however, and consequently kinetic studies do not unequivocally differentiate between jaundice of obstructive and hepatocellular origin. A markedly increased uptake (a high Ka) was noticed in alcoholics and patients taking phenobarbital and diphenylhydantoin possibly because of drug-induced membrane alterations. When the alcoholics developed hepatocellular injury the Ka converted to normal values. Thus, 99mTc-EHIDA kinetics may be useful in the follow-up of patients with established or suspected alcoholism by virtue of the fact that it appears to be a sensitive monitor of functional changes in hepatocyte plasma membrane properties.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861781     DOI: 10.1007/bf00252882

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  Quantitative measurement of liver function with radioactive rose bengal.

Authors:  M DORLEYN; J COENEGRACHT
Journal:  Medicamundi       Date:  1959

2.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

3.  Mechanism of phenobarbital-induced hypercholeresis in the rat.

Authors:  P Berthelot; S Erlinger; D Dhumeaux; A M Preaux
Journal:  Am J Physiol       Date:  1970-09

Review 4.  Hepatic bile formation. (Second of two parts).

Authors:  N B Javitt
Journal:  N Engl J Med       Date:  1976-12-30       Impact factor: 91.245

5.  A mathematical model for the liver uptake and excretion of 99mTc-diethyl IDA.

Authors:  L Gelius; A Skretting; M Aas
Journal:  Eur J Nucl Med       Date:  1981-04

6.  Differential diagnosis of jaundice by 99mTc-IDA hepatobiliary imaging.

Authors:  C Fonseca; L Rosenthall; D Greenberg; M Hernandez; A Arzoumanian
Journal:  Clin Nucl Med       Date:  1979-04       Impact factor: 7.794

7.  Diagnosis of hepatobiliary disease by 99mTc-HIDA cholescintigraphy.

Authors:  L Rosenthall; E A Shaffer; R Lisbona; P Pare
Journal:  Radiology       Date:  1978-02       Impact factor: 11.105

8.  Stimulation of hepatic sodium and potassium-activated adenosine triphosphatase activity by phenobarbital. Its possible role in regulation of bile flow.

Authors:  F R Simon; E Sutherland; L Accatino
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid.

Authors:  M D Loberg; M Cooper; E Harvey; P Callery; W Faith
Journal:  J Nucl Med       Date:  1976-07       Impact factor: 10.057

10.  Tc-99m-diethyl-IDA imaging: clinical evaluation in jaundiced patients.

Authors:  S Pauwels; L Piret; A Schoutens; G Vandermoten; C Beckers
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

View more
  1 in total

1.  Plasma transport of 99mTc-p-butyl-IDA.

Authors:  A Champailler; E Gremillet; M Decousus; A Kassir; M Voutay; J C Healy
Journal:  Eur J Nucl Med       Date:  1985
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.